Learning Objectives
Upon completion of this activity, participants should be able to:

• Apply the use of Apolipoprotein B into clinical practice, when to measure and remeasure, and its importance in risk assessment
• Implement Calcium score for the decision making for cardiovascular therapies based on the evidence
• Discuss Lipoprotein(a) composition, how it is determined, when to measure, and how to translate into cardiovascular risk assessment and management

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

"Credit (if available) is announced on the Group Home page. All sessions are reviewed individually, and credit is pulled for any that does not meet the criteria."